TY - JOUR
AU - Bedston, Stuart
AU - Almaghrabi, Fatima
AU - Patterson, Lynsey
AU - Agrawal, Utkarsh
AU - Woolford, Lana
AU - Anand, Sneha N.
AU - Joy, Mark
AU - Crawford, Anna
AU - Goudie, Rosalind
AU - Byford, Rachel
AU - Abbasizanjani, Hoda
AU - Smith, Deb
AU - Laidlaw, Lynn
AU - Akbari, Ashley
AU - Sullivan, Christopher
AU - Bradley, Declan T.
AU - Lyons, Ronan A.
AU - de Lusignan, Simon
AU - Hobbs, F.D. Richard
AU - Robertson, Chris
AU - Sheikh, Aziz
AU - Shi, Ting
PY - 2023
DA - December
TI - Risk of severe COVID-19 outcomes after autumn 2022 COVID-19 booster vaccinations: a pooled analysis of national prospective cohort studies involving 7.4 million adults in England, Northern Ireland, Scotland and Wales
JO - The Lancet Regional Health - Europe
VL - 37
DO - https://doi.org/10.1016/j.lanepe.2023.100816
AB - BackgroundUK COVID-19 vaccination policy has evolved to offering COVID-19booster dosesto individuals at increased risk of severe Illness from COVID-19. Building on our analyses of vaccine effectiveness of first, second and initial booster doses, we aimed to identify individuals at increased risk of severe outcomes (i.e., COVID-19 related hospitalisation or death) post the autumn 2022 booster dose.
PB - Elsevier
UR - https://publichealthscotland.scot/id/164897
KW - Coronavirus (COVID-19)
ER